| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/21/2011 | WO2011025270A3 Metformin caffeic acid salt, method for preparing same, pharmaceutical composition comprising same, and combined formulation comprising same |
| 07/21/2011 | WO2011025269A3 Metformin taurate, method for preparing same, pharmaceutical composition comprising same, and combined formulation comprising same |
| 07/21/2011 | WO2011025267A3 Metformin methanesulfonate, method for preparing same, pharmaceutical composition comprising same, and combined formulation comprising same |
| 07/21/2011 | WO2011022548A3 Ketoreductase polypeptides for the preparation of phenylephrine |
| 07/21/2011 | WO2011014611A3 Preparation of olmesartan medoxomil |
| 07/21/2011 | WO2011009987A3 Aureolic acid derivatives, the method for preparation thereof and the uses thereof |
| 07/21/2011 | WO2011008956A3 Mammalian genes involved in infection |
| 07/21/2011 | WO2011008947A3 Treatment and diagnosis of immune disorders |
| 07/21/2011 | WO2011000811A4 Pharmaceutical solutions for infusion |
| 07/21/2011 | WO2010151674A3 Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene |
| 07/21/2011 | WO2010129746A3 Treatment of tristetraproline (ttp) related diseases by inhibition of natural antisense transcript to ttp |
| 07/21/2011 | WO2010126607A3 Synthesis of tetracyclines and intermediates thereto |
| 07/21/2011 | WO2010121212A3 Indoline scaffold shp-2 inhibitors and method of treating cancer |
| 07/21/2011 | WO2010100512A8 Novel crystalline hydrate, amorphous and polymorphic forms of dihydro-benzoxazole-6-yl-acetamide derivative and processes for their preparation |
| 07/21/2011 | WO2010091808A8 Fused pyrimidines |
| 07/21/2011 | WO2010071988A8 Plasmalogen compounds, pharmaceutical compositions containing the same and methods for treating diseases of the aging |
| 07/21/2011 | WO2010071783A8 Thiazoles as cannabinoid receptor ligands |
| 07/21/2011 | WO2010069621A8 Treatment of vaginal atrophy in women with cardiovascular pathology risk |
| 07/21/2011 | WO2010003760A3 Fluoro-substituted 3,4-diaryl-4,5-dihydro-1h-pyrazole-1-carboxamidine derivatives having cb1-antagonistic activity |
| 07/21/2011 | WO2007117911A3 Novel formulations |
| 07/21/2011 | US20110179509 Use of Afamin for Treating Fertility Disorders |
| 07/21/2011 | US20110179506 New i-crei derived single-chain meganuclease and uses thereof |
| 07/21/2011 | US20110179502 Modulation of gm98 (mrf) in remyelination |
| 07/21/2011 | US20110178470 Pharmaceutical compositions comprising boronic acid compounds |
| 07/21/2011 | US20110178379 Tissue assessment |
| 07/21/2011 | US20110178294 Novel carboxylic acid derivatives, their preparation and use |
| 07/21/2011 | US20110178181 Personal Care Compositions Comprising A Methyl Naphthalenyl Ketone Or A Derivative Thereof |
| 07/21/2011 | US20110178180 Deuterium-enriched colchicine, thiocolchicine, and derivatives thereof; methods of preparation; and use thereof |
| 07/21/2011 | US20110178179 1-amino-alkylcyclohexane derivatives for the treatment of cognitive impairment in tinnitus |
| 07/21/2011 | US20110178178 Treatment of Motor Fluctuations |
| 07/21/2011 | US20110178177 Topical formulations for treatment of neuropathy |
| 07/21/2011 | US20110178176 Use of a virucidal preparation on an area of the face for prevention of transmission or contraction of viral illnesses, or to shorten the duration of, or lessen the severity of viral illnesses |
| 07/21/2011 | US20110178175 Method for producing mechanically activated amorphous and amorphocrystalline compounds of gluconic acid calcium salt |
| 07/21/2011 | US20110178174 Salts of tramadol and ibuprofen and their crystal form in the treatment of pain |
| 07/21/2011 | US20110178173 Anti-degradation agent |
| 07/21/2011 | US20110178172 Inhibitors of Carnitin-Palmitoyl-Tranferase-1 for the Treatment and prevention of disorders caused by delipidation of neural tissue |
| 07/21/2011 | US20110178171 Compounds for cancer therapy |
| 07/21/2011 | US20110178170 Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering |
| 07/21/2011 | US20110178169 Use of 5-hydroxy-2-hydroxymethyl-y-pyrone (hmp) as a leishmanicidal agent |
| 07/21/2011 | US20110178168 Coumarin compounds for the treatment of cardiovascular diseases and a process for preparing the same |
| 07/21/2011 | US20110178167 Method for inhibiting activity and/or expression of matrix metalloproteinase, inhibiting phosphorylation of mitogen-activated protein kinase, and/or promoting expression of collagen using terminalia catappa leaf extract |
| 07/21/2011 | US20110178166 Methods of using low-dose doxepin for the improvement of sleep |
| 07/21/2011 | US20110178165 Tetrahydrofuranyl sulfonamides and pharmaceutical compositions thereof |
| 07/21/2011 | US20110178164 Application on monoolein as a new helper lipid in transfection |
| 07/21/2011 | US20110178163 Mir-182 in the diagnosis and treatment of cancer |
| 07/21/2011 | US20110178162 Targeting pax2 for the induction of defb1-mediated tumor immunity and cancer therapy |
| 07/21/2011 | US20110178160 Inhibition of Interaction of PSD93 and PSDS95 with nNOS and NMDA Receptors |
| 07/21/2011 | US20110178159 Inhibitory rnas that regulate hematopoietic cells |
| 07/21/2011 | US20110178158 Set of Antiangiogenic Molecules and Use Thereof |
| 07/21/2011 | US20110178157 Modulation of hsp47 expression |
| 07/21/2011 | US20110178156 Method of suppressing pRb deficiency-induced tumor formation |
| 07/21/2011 | US20110178155 Silencing of csn5 gene expression using interfering rna |
| 07/21/2011 | US20110178154 gene expression profile that predicts ovarian cancer subject response to chemotherapy |
| 07/21/2011 | US20110178153 Methods of treating chemoresistance and relapse in cancer cells |
| 07/21/2011 | US20110178152 Composition comprising s-allylmercapto-n-acetylcysteine (assnac) for up-regulation of cellular glutathione level |
| 07/21/2011 | US20110178151 Compounds and methods of treating obesity |
| 07/21/2011 | US20110178150 Use of Indole Derivatives as NURR-1 Activators for Treating Parkinson's Disease |
| 07/21/2011 | US20110178148 Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators |
| 07/21/2011 | US20110178147 Compositions and methods for controlling pupil dilation |
| 07/21/2011 | US20110178146 Thiophene-carboxamides useful as inhibitors of protein kinases |
| 07/21/2011 | US20110178145 Alpha-2 adrenergic agonist having long duration ofintraocular pressure-lowering effect |
| 07/21/2011 | US20110178144 Therapeutic compounds |
| 07/21/2011 | US20110178143 Therapeutic compounds |
| 07/21/2011 | US20110178142 Pharmaceutical composition for therapeutic or prophylactic treatment of bacterial infections and associated diseases |
| 07/21/2011 | US20110178141 Thiazoliums and Their Use for Treating Protein Aging Associated Diseases |
| 07/21/2011 | US20110178140 Sulfur containing pyrazole-heterocycle derivatives as cannabinoid cb1 receptor antagonists |
| 07/21/2011 | US20110178139 Pyridoxamine for the Treatment of Diabetic Kidney Disease |
| 07/21/2011 | US20110178138 Inhibitors of protein prenyltransferases |
| 07/21/2011 | US20110178137 Diaryl urea for treating heart failure |
| 07/21/2011 | US20110178136 Heterocyclic inhibitors of mek and methods of use thereof |
| 07/21/2011 | US20110178135 Salts and crystalline forms of a factor xa inhibitor |
| 07/21/2011 | US20110178134 Novel phenyl-substituted imidazolidines, process for preparation thereof, medicaments comprising said compounds and use thereof |
| 07/21/2011 | US20110178133 Calcium receptor modulating agents |
| 07/21/2011 | US20110178131 Compounds Which Have Activity At M1 Receptor And Their Uses In Medicine |
| 07/21/2011 | US20110178130 MACROCYCLIC UREA AND SULFAMIDE DERIVATIVES AS INHIBITORS OF TAFIa |
| 07/21/2011 | US20110178129 Inhibitors of flaviviridae viruses |
| 07/21/2011 | US20110178128 Benzimidazole compound in crystal form and salt thereof |
| 07/21/2011 | US20110178127 Amine compounds and medical uses thereof |
| 07/21/2011 | US20110178126 Pyrazolylbenzothiazole derivatives and their use as therapeutic agents |
| 07/21/2011 | US20110178125 Use of galr3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| 07/21/2011 | US20110178124 Pyridinium and quinolinium derivatives |
| 07/21/2011 | US20110178123 Nonpeptide hiv-1 protease inhibitors |
| 07/21/2011 | US20110178122 Quinolizidinone M1 Receptor Positive Allosteric Modulators |
| 07/21/2011 | US20110178121 Methods for Treating Pain |
| 07/21/2011 | US20110178120 Hiv integrase inhibitors from pyridoxine |
| 07/21/2011 | US20110178119 Bridged N-Bicyclic Sulfonamido Inhibitors of Gamma Secretase |
| 07/21/2011 | US20110178118 Palonosetron for the treatment of chemotherapy induced emeses |
| 07/21/2011 | US20110178117 Oxazolobenzimidazole derivatives |
| 07/21/2011 | US20110178116 Methods of stimulating immune response in certain individuals |
| 07/21/2011 | US20110178115 Azaindole derivatives as crth2 receptor antagonists |
| 07/21/2011 | US20110178114 Topical regional neuro-affective therapy |
| 07/21/2011 | US20110178113 Methods of treating traveler's diarrhea and hepatic encephalopathy |
| 07/21/2011 | US20110178112 PPAR Modulators |
| 07/21/2011 | US20110178111 Long-term treatment of symptomatic heart failure |
| 07/21/2011 | US20110178110 Genotype and Expression Analysis for Use in Predicting Outcome and Therapy Selection |
| 07/21/2011 | US20110178108 Group of amino substituted benzoyl derivatives and their preparation and their use |
| 07/21/2011 | US20110178107 Hcv protease inhibitors |
| 07/21/2011 | US20110178106 5-quinolinone and imidazopyridine compounds and use thereof |
| 07/21/2011 | US20110178105 Clinical benefits of eicosapentaenoic acid in humans |
| 07/21/2011 | US20110178104 Anti-Heparin Compounds |